This report contains market size and forecasts of Cardiac Resynchronisation Therapy (CRT) Device in global, including the following market information:
Global Cardiac Resynchronisation Therapy (CRT) Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac Resynchronisation Therapy (CRT) Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac Resynchronisation Therapy (CRT) Device companies in 2021 (%)
The global Cardiac Resynchronisation Therapy (CRT) Device market was valued at 6289.7 million in 2021 and is projected to reach US$ 9116.3 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiac Resynchronization Therapy Pacemakers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Resynchronisation Therapy (CRT) Device include Medtronic, Boston Scientific, Biotronik, Livanova, Abbott, Cook Medical and Sorin Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Resynchronisation Therapy (CRT) Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Resynchronisation Therapy (CRT) Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronisation Therapy (CRT) Device Market Segment Percentages, by Type, 2021 (%)
Cardiac Resynchronization Therapy Pacemakers
Cardiac Resynchronization Therapy Defibrillators
Global Cardiac Resynchronisation Therapy (CRT) Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronisation Therapy (CRT) Device Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Cardiac Resynchronisation Therapy (CRT) Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronisation Therapy (CRT) Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Resynchronisation Therapy (CRT) Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac Resynchronisation Therapy (CRT) Device revenues share in global market, 2021 (%)
Key companies Cardiac Resynchronisation Therapy (CRT) Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac Resynchronisation Therapy (CRT) Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Biotronik
Livanova
Abbott
Cook Medical
Sorin Group